jcav11p1985s1
jcav11p1985s1
rs6941653 Genotype
Stage Smoke TT TC CC P_interaction
Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P
NO 497/1111 1.00 Reference 286/588 1.10(0.92-1.31) 0.292 42/69 1.34(0.90-2.00) 0.155
NJMU GWAS 0.287
Yes 863/835 3.17(2.67-3.77) 6.58E-39 566/420 4.13(3.41-5.01) 1.51E-47 77/54 4.27(2.93-6.22) 3.81E-14
NO 353/364 1.00 Reference 186/166 1.15(0.89-1.49) 0.272 26/22 1.22(0.68-2.20) 0.501
Validation 0.644
Yes 262/275 1.07(0.83-1.38) 0.597 160/124 1.45(1.07-1.97) 0.016 20/18 1.25(0.64-2.43) 0.513
NO 850/1475 1.00 Reference 472/754 1.09(0.95-1.26) 0.227 68/91 1.29(0.93-1.79) 0.129
Combined 0.172
Yes 1125/1110 2.20(1.91-2.53) 3.41E-28 726/544 2.89(2.47-3.39) 1.80E-39 97/72 2.88(2.08-3.98) 1.69E-10
rs402969 Genotype
Stage Smoke CC CT TT P_interaction
Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P
NO 539/1188 1.00 Reference 249/521 1.07(0.89-1.28) 0.498 37/59 1.33(0.87-2.04) 0.189
NJMU GWAS 0.341
Yes 983/913 3.25(2.75-3.85) 3.89E-43 457/356 3.85(3.16-4.69) 6.61E-41 66/40 5.00(3.29-7.59) 4.47E-14
NO 348/358 1.00 Reference 191/184 1.06(0.83-1.37) 0.628 26/20 1.33(0.73-2.43) 0.355
Validation 0.365
Yes 281/290 1.07(0.83-1.38) 0.614 143/118 1.33(1.00-1.82) 0.049 14/11 1.39(0.62-3.14) 0.423
NO 887/1546 1.00 Reference 440/705 1.09(0.95-1.27) 0.226 63/79 1.36(0.97-1.92) 0.077
Combined 0.222
Yes 1264/1203 2.28(1.99-2.61) 3.54E-32 600/474 2.73(2.32-3.22) 2.07E-33 80/51 3.39(2.35-4.91) 7.94E-11
Table S4. Interaction analysis between risk variant rs6941653 and SNP rs402969.
rs402969 Genotype
rs6941653
Stage CC CT TT P_interaction
Genotype
Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P Cases/Controls OR (95%CI) P
TT 894/1357 1.00 Reference 413/532 1.18(1.01-1.38) 0.039 53/57 1.37(0.93-2.04) 0.116
NJMU GWAS TC 548/661 1.25(1.08-1.44) 0.003 262/307 1.32(1.09-1.59) 0.005 42/40 1.64(1.04-2.58) 0.033 0.787
CC 80/83 1.37(0.98-1.90) 0.062 31/38 1.31(0.80-2.16) 0.283 8/2 5.77(1.19-27.94) 0.029
TT 365/424 1.00 Reference 210/191 1.28(1.02-1.63) 0.036 26/18 1.66(0.89-3.08) 0.108
Validation TC 233/178 1.52(1.19-1.93) 6.79E-04 98/93 1.24(0.90-1.70) 0.185 9/11 0.96(0.39-2.34) 0.923 0.094
CC 24/24 1.17(0.65-2.09) 0.904 16/14 1.32(0.63-2.74) 0.461 5/2 2.92(0.56-15.14) 0.203
TT 1259/1781 1.00 Reference 623/723 1.23(1.07-1.40) 0.002 79/75 1.48(1.07-2.06) 0.019
Combined TC 781/839 1.30(1.15-1.47) 3.28E-05 360/400 1.30(1.10-1.53) 0.002 51/51 1.45(0.97-2.17) 0.068 0.276
CC 104/107 1.32(1.00-1.76) 0.054 47/52 1.31(0.87-1.97) 0.195 13/4 4.62(1.49-14.38) 0.008
Age, gender, smoking and principal components were adjusted when appropriate.
Table S5. Pathway enrichment and GO analysis.
Gene Category Term Count % P Fold a Bonferroni b
KEGG_PATHWAY Olfactory transduction 194 46.6 2.10E-214 14.0 2.00E-212
GO_MF olfactory receptor activity 196 47.1 8.00E-243 23.9 1.50E-240
GO_MF G-protein coupled receptor activity 210 50.5 1.00E-215 15.6 2.00E-213
GO_MF odorant binding 47 11.3 4.10E-55 26.9 7.90E-53
GO_MF transmembrane signaling receptor activity 48 11.5 1.20E-36 11.8 2.40E-34
GO_MF type I interferon receptor binding 8 1.9 1.40E-08 24.7 2.60E-06
GO_MF trace-amine receptor activity 4 1.0 1.30E-04 35.1 2.50E-02
GO_MF adrenergic receptor activity 4 1.0 2.20E-04 30.1 4.20E-02
GO_CC plasma membrane 227 54.6 4.90E-68 2.9 5.50E-66
GO_CC integral component of membrane 240 57.7 5.80E-59 2.5 6.50E-57
GO_CC keratin filament 12 2.9 2.60E-06 6.4 2.90E-04
GO_BP detection of chemical stimulus involved in sensory perception of smell 196 47.1 5.70E-246 24.5 2.80E-243
OPRM1
GO_BP G-protein coupled receptor signaling pathway 204 49.0 2.10E-183 12.1 1.00E-180
GO_BP sensory perception of smell 57 13.7 1.00E-56 19.0 4.90E-54
GO_BP detection of chemical stimulus involved in sensory perception 48 11.5 2.90E-56 26.8 1.50E-53
GO_BP natural killer cell activation involved in immune response 8 1.9 3.20E-08 22.4 1.60E-05
GO_BP positive regulation of peptidyl-serine phosphorylation of STAT protein 8 1.9 3.20E-08 22.4 1.60E-05
GO_BP T cell activation involved in immune response 8 1.9 1.00E-07 19.3 5.00E-05
GO_BP regulation of type I interferon-mediated signaling pathway 8 1.9 3.70E-07 16.4 1.80E-04
GO_BP B cell proliferation 8 1.9 1.70E-06 13.3 8.50E-04
GO_BP response to exogenous dsRNA 8 1.9 2.70E-06 12.5 1.30E-03
GO_BP B cell differentiation 9 2.2 3.10E-05 7.2 1.50E-02
GO_BP adenylate cyclase-activating serotonin receptor signaling pathway 5 1.2 7.60E-05 20.4 3.70E-02
GO_BP humoral immune response 8 1.9 9.00E-05 7.5 4.40E-02
NLRP8 KEGG_PATHWAY Olfactory transduction 176 16.1 3.10E-110 6.7 7.60E-108
GO_MF olfactory receptor activity 177 16.2 1.00E-111 7.7 9.10E-109
GO_MF G-protein coupled receptor activity 193 17.7 3.30E-85 5.1 2.90E-82
GO_MF odorant binding 45 4.1 1.40E-31 9.1 1.20E-28
GO_MF transmembrane signaling receptor activity 50 4.6 1.80E-18 4.4 1.50E-15
GO_MF type I interferon receptor binding 8 0.7 1.50E-05 8.8 1.30E-02
GO_MF structural molecule activity 31 2.8 2.50E-05 2.3 2.10E-02
GO_CC plasma membrane 379 34.7 1.30E-33 1.7 5.80E-31
GO_CC integral component of membrane 404 37.0 3.50E-21 1.5 1.60E-18
GO_CC extracellular region 127 11.6 3.30E-06 1.5 1.50E-03
GO_BP detection of chemical stimulus involved in sensory perception of smell 177 16.2 1.50E-113 7.8 4.70E-110
GO_BP G-protein coupled receptor signaling pathway 200 18.3 1.80E-72 4.2 5.70E-69
GO_BP sensory perception of smell 57 5.2 1.80E-31 6.7 5.70E-28
GO_BP detection of chemical stimulus involved in sensory perception 45 4.1 5.70E-31 8.9 1.80E-27
GO_BP keratinocyte differentiation 17 1.6 1.90E-06 4.2 6.10E-03
a
Fold enrichment in each pathway or GO process.
b
P values after taking Bonferroni correction.
Supplementary Figure 1. Rs805165 was significantly associated with the expression of AC010525.7 and AC024580.1 in lung tissues based
on GTEx v7 database.
Supplementary Figure 2. Expression of OPRM1 and NLRP8 in 60 paired lung tumor tissues and adjacent normal tissues based on
GSE19804.